The CTN+ | Le Réseau+
@ctnplus.bsky.social
CIHR Pan-Canadian Network for HIV and STBBI Clinical Trials Research | Réseau pancanadien pour des essais cliniques sur le VIH et autres ITSS
Visit us: ctnplus.ca
Visit us: ctnplus.ca
Pinned
We're excited to announce that applications for the 2026/27 cohort of the CTN+ Postdoctoral Fellowship Program are now open!
Are you a postdoctoral fellow supervised by a CTN+ researcher? Apply by February 20th to join our network.
✒️Apply now: https://bit.ly/4jC5e2p
Are you a postdoctoral fellow supervised by a CTN+ researcher? Apply by February 20th to join our network.
✒️Apply now: https://bit.ly/4jC5e2p
Join the IPVS for an important webinar discussion on the latest insights into HPV-based #CervicalCancer screening for women living with HIV, featuring previous CTN+ postdoctoral fellow Dr. Elisabeth McClymont as moderator.
📆 Jan 28th
🕰️12pm EST
Register here: https://bit.ly/3YJ28A9
📆 Jan 28th
🕰️12pm EST
Register here: https://bit.ly/3YJ28A9
January 19, 2026 at 9:02 PM
Join the IPVS for an important webinar discussion on the latest insights into HPV-based #CervicalCancer screening for women living with HIV, featuring previous CTN+ postdoctoral fellow Dr. Elisabeth McClymont as moderator.
📆 Jan 28th
🕰️12pm EST
Register here: https://bit.ly/3YJ28A9
📆 Jan 28th
🕰️12pm EST
Register here: https://bit.ly/3YJ28A9
Two Lancet publications led by Dr. Nadine Kronfli examine global evidence to guide improvements in #PrisonHealth care services.
"Prison health is public health. To reach global elimination goals, no community should be left behind," says Dr. Kronfli.
Learn more: https://bit.ly/3N7Coec
"Prison health is public health. To reach global elimination goals, no community should be left behind," says Dr. Kronfli.
Learn more: https://bit.ly/3N7Coec
January 13, 2026 at 7:07 PM
Two Lancet publications led by Dr. Nadine Kronfli examine global evidence to guide improvements in #PrisonHealth care services.
"Prison health is public health. To reach global elimination goals, no community should be left behind," says Dr. Kronfli.
Learn more: https://bit.ly/3N7Coec
"Prison health is public health. To reach global elimination goals, no community should be left behind," says Dr. Kronfli.
Learn more: https://bit.ly/3N7Coec
We're excited to announce that applications for the 2026/27 cohort of the CTN+ Postdoctoral Fellowship Program are now open!
Are you a postdoctoral fellow supervised by a CTN+ researcher? Apply by February 20th to join our network.
✒️Apply now: https://bit.ly/4jC5e2p
Are you a postdoctoral fellow supervised by a CTN+ researcher? Apply by February 20th to join our network.
✒️Apply now: https://bit.ly/4jC5e2p
January 12, 2026 at 9:09 PM
We're excited to announce that applications for the 2026/27 cohort of the CTN+ Postdoctoral Fellowship Program are now open!
Are you a postdoctoral fellow supervised by a CTN+ researcher? Apply by February 20th to join our network.
✒️Apply now: https://bit.ly/4jC5e2p
Are you a postdoctoral fellow supervised by a CTN+ researcher? Apply by February 20th to join our network.
✒️Apply now: https://bit.ly/4jC5e2p
CTN+ BC–Yukon Regional Team Co-lead Dr. Troy Grennan is vice-chair of an advisory body that recently provided reccomendations to the Public Health Agency of Canada on the use of prophylactic doxycycline for the prevention of bacterial STTBIs, such as syphilis.
Learn more:
https://bit.ly/4pzIrFP
Learn more:
https://bit.ly/4pzIrFP
January 9, 2026 at 10:30 PM
CTN+ BC–Yukon Regional Team Co-lead Dr. Troy Grennan is vice-chair of an advisory body that recently provided reccomendations to the Public Health Agency of Canada on the use of prophylactic doxycycline for the prevention of bacterial STTBIs, such as syphilis.
Learn more:
https://bit.ly/4pzIrFP
Learn more:
https://bit.ly/4pzIrFP
⏰ One week to go — don’t miss out!
Final call to submit your research abstract to the 16th International Workshop on Women & HIV and contribute to the global dialogue on #WomenandHIV
🗓 Deadline: Fri, 16 Jan 2026 | 23:59 CET
🔗 Submit: https://amededu.co/3Nw1aVf
Final call to submit your research abstract to the 16th International Workshop on Women & HIV and contribute to the global dialogue on #WomenandHIV
🗓 Deadline: Fri, 16 Jan 2026 | 23:59 CET
🔗 Submit: https://amededu.co/3Nw1aVf
January 9, 2026 at 5:03 PM
⏰ One week to go — don’t miss out!
Final call to submit your research abstract to the 16th International Workshop on Women & HIV and contribute to the global dialogue on #WomenandHIV
🗓 Deadline: Fri, 16 Jan 2026 | 23:59 CET
🔗 Submit: https://amededu.co/3Nw1aVf
Final call to submit your research abstract to the 16th International Workshop on Women & HIV and contribute to the global dialogue on #WomenandHIV
🗓 Deadline: Fri, 16 Jan 2026 | 23:59 CET
🔗 Submit: https://amededu.co/3Nw1aVf
A team including Dr. Souradet Shaw, an Advancing Health scientist and professor at the University of Manitoba, found that female sex workers in Kenya had widely varying rates of #HIV infection, depending on which area of Nairobi they worked in.
Learn more: https://bit.ly/45gGfvo
Learn more: https://bit.ly/45gGfvo
January 7, 2026 at 7:24 PM
A team including Dr. Souradet Shaw, an Advancing Health scientist and professor at the University of Manitoba, found that female sex workers in Kenya had widely varying rates of #HIV infection, depending on which area of Nairobi they worked in.
Learn more: https://bit.ly/45gGfvo
Learn more: https://bit.ly/45gGfvo
What is #doxyPEP?
Doxypep is a prescription that an significantly reduce the risk of contracting certain sexually transmitted infections (STIs), acting like a "morning after pill", especially for men who have sex with men and trans women.
💡 https://bit.ly/4p0lQSw
Doxypep is a prescription that an significantly reduce the risk of contracting certain sexually transmitted infections (STIs), acting like a "morning after pill", especially for men who have sex with men and trans women.
💡 https://bit.ly/4p0lQSw
January 5, 2026 at 6:30 PM
What is #doxyPEP?
Doxypep is a prescription that an significantly reduce the risk of contracting certain sexually transmitted infections (STIs), acting like a "morning after pill", especially for men who have sex with men and trans women.
💡 https://bit.ly/4p0lQSw
Doxypep is a prescription that an significantly reduce the risk of contracting certain sexually transmitted infections (STIs), acting like a "morning after pill", especially for men who have sex with men and trans women.
💡 https://bit.ly/4p0lQSw
An innovative project will train people with lived experience from across the Prairies to work with researchers on developing clinical trials focused on HIV and other STBBIs, such as #syphilis.
“This is a first-of-its-kind project in Canada,” said project head Dr. Keynan.
https://bit.ly/4pNtMb7
“This is a first-of-its-kind project in Canada,” said project head Dr. Keynan.
https://bit.ly/4pNtMb7
January 2, 2026 at 7:02 PM
An innovative project will train people with lived experience from across the Prairies to work with researchers on developing clinical trials focused on HIV and other STBBIs, such as #syphilis.
“This is a first-of-its-kind project in Canada,” said project head Dr. Keynan.
https://bit.ly/4pNtMb7
“This is a first-of-its-kind project in Canada,” said project head Dr. Keynan.
https://bit.ly/4pNtMb7
Happy New Year, Canada! 🎊
We're so excited about everything 2026 has in store, including:
💊 New Canadian PrEP and PEP guidelines
🇨🇦 Building regional capacity in Phase 2 of the CTN+
🍎The launch of a free online course to empower community engagement in clinical research
We hope you'll join us!💓
We're so excited about everything 2026 has in store, including:
💊 New Canadian PrEP and PEP guidelines
🇨🇦 Building regional capacity in Phase 2 of the CTN+
🍎The launch of a free online course to empower community engagement in clinical research
We hope you'll join us!💓
January 1, 2026 at 5:02 PM
Happy New Year, Canada! 🎊
We're so excited about everything 2026 has in store, including:
💊 New Canadian PrEP and PEP guidelines
🇨🇦 Building regional capacity in Phase 2 of the CTN+
🍎The launch of a free online course to empower community engagement in clinical research
We hope you'll join us!💓
We're so excited about everything 2026 has in store, including:
💊 New Canadian PrEP and PEP guidelines
🇨🇦 Building regional capacity in Phase 2 of the CTN+
🍎The launch of a free online course to empower community engagement in clinical research
We hope you'll join us!💓
🔉The Canadian Calls to Action: Advancing the health and rights of women living with HIV
Celebrate the launch of the Canadian Calls to Action with a webinar on the sexual and #ReproductiveHealth and rights of women living with HIV.
🕰️ Jan 30, 2026, 10:00am PST
Register: https://bit.ly/4oVeakw
Celebrate the launch of the Canadian Calls to Action with a webinar on the sexual and #ReproductiveHealth and rights of women living with HIV.
🕰️ Jan 30, 2026, 10:00am PST
Register: https://bit.ly/4oVeakw
December 22, 2025 at 6:01 PM
🔉The Canadian Calls to Action: Advancing the health and rights of women living with HIV
Celebrate the launch of the Canadian Calls to Action with a webinar on the sexual and #ReproductiveHealth and rights of women living with HIV.
🕰️ Jan 30, 2026, 10:00am PST
Register: https://bit.ly/4oVeakw
Celebrate the launch of the Canadian Calls to Action with a webinar on the sexual and #ReproductiveHealth and rights of women living with HIV.
🕰️ Jan 30, 2026, 10:00am PST
Register: https://bit.ly/4oVeakw
The next KT Canada Seminar will be with Dr. Guillaume Fontaine, co-lead of the CTN+ Methods Think Tank, who'll be giving the presentation "A Global Review of >600 Implementation Science Theories, Models and Frameworks". #SciComm
📆 Noon ET, Thurs, Jan 8
Register now: https://bit.ly/4pE04oT
📆 Noon ET, Thurs, Jan 8
Register now: https://bit.ly/4pE04oT
December 18, 2025 at 6:02 PM
The next KT Canada Seminar will be with Dr. Guillaume Fontaine, co-lead of the CTN+ Methods Think Tank, who'll be giving the presentation "A Global Review of >600 Implementation Science Theories, Models and Frameworks". #SciComm
📆 Noon ET, Thurs, Jan 8
Register now: https://bit.ly/4pE04oT
📆 Noon ET, Thurs, Jan 8
Register now: https://bit.ly/4pE04oT
Reposted by The CTN+ | Le Réseau+
🌐 #IAS2025 showed even amid an unprecedented funding crisis, the #HIV response remains resilient, innovative & united.
Nearly 4,000 people joined in #Kigali & virtually, with strong participation from across Africa.
🔎Explore the IAS 2025 conference report: zurl.co/mdpzv
#RethinkRebuildRise
Nearly 4,000 people joined in #Kigali & virtually, with strong participation from across Africa.
🔎Explore the IAS 2025 conference report: zurl.co/mdpzv
#RethinkRebuildRise
December 18, 2025 at 1:07 PM
🌐 #IAS2025 showed even amid an unprecedented funding crisis, the #HIV response remains resilient, innovative & united.
Nearly 4,000 people joined in #Kigali & virtually, with strong participation from across Africa.
🔎Explore the IAS 2025 conference report: zurl.co/mdpzv
#RethinkRebuildRise
Nearly 4,000 people joined in #Kigali & virtually, with strong participation from across Africa.
🔎Explore the IAS 2025 conference report: zurl.co/mdpzv
#RethinkRebuildRise
Registration is now open for the CAHR 2026 (@cahr-acrv.bsky.social)!
📍Winnipeg, Manitoba
📆 Apr 23–26
🌄 Theme: Under open skies: Rising to meet unprecedented challenges in the HIV response
Early Bird Conference rates are available until Wed, March 18.
Learn more & register: https://bit.ly/48RwgxE
📍Winnipeg, Manitoba
📆 Apr 23–26
🌄 Theme: Under open skies: Rising to meet unprecedented challenges in the HIV response
Early Bird Conference rates are available until Wed, March 18.
Learn more & register: https://bit.ly/48RwgxE
December 15, 2025 at 6:04 PM
Registration is now open for the CAHR 2026 (@cahr-acrv.bsky.social)!
📍Winnipeg, Manitoba
📆 Apr 23–26
🌄 Theme: Under open skies: Rising to meet unprecedented challenges in the HIV response
Early Bird Conference rates are available until Wed, March 18.
Learn more & register: https://bit.ly/48RwgxE
📍Winnipeg, Manitoba
📆 Apr 23–26
🌄 Theme: Under open skies: Rising to meet unprecedented challenges in the HIV response
Early Bird Conference rates are available until Wed, March 18.
Learn more & register: https://bit.ly/48RwgxE
This week, @cbcradiocanada.bsky.social's The Current shared actually good news in the form new drug that is showing incredible promise in fighting HIV/AIDS, lenacapavir. They spoke with the CTN+'s Dr. Darrell Tan about the drug's possible impact in Africa.
📻 Listen now: https://bit.ly/3XNbf29
📻 Listen now: https://bit.ly/3XNbf29
December 12, 2025 at 7:33 PM
This week, @cbcradiocanada.bsky.social's The Current shared actually good news in the form new drug that is showing incredible promise in fighting HIV/AIDS, lenacapavir. They spoke with the CTN+'s Dr. Darrell Tan about the drug's possible impact in Africa.
📻 Listen now: https://bit.ly/3XNbf29
📻 Listen now: https://bit.ly/3XNbf29
What a wonderfully written, thoughtful article. We're glad to hear that the new guidelines resonate with your work and experience, and hope others working within our healthcare system find it helpful. 💗
Canada’s updated PrEP and PEP guideline strengthens our prevention efforts. It centres accessibility, equity, and clear communication, reflecting what communities have needed for years. My new blog explores why this matters.
#UequalsU #PLHIVLeadersNOW #HIVPrevention
#UequalsU #PLHIVLeadersNOW #HIVPrevention
What New PrEP and PEP Guidelines Mean for Prevention Efforts in Canada
A clearer path forward for providers, advocates, and everyone working to prevent new HIV diagnoses
theaccidentalhivactivist.substack.com
December 11, 2025 at 5:38 PM
What a wonderfully written, thoughtful article. We're glad to hear that the new guidelines resonate with your work and experience, and hope others working within our healthcare system find it helpful. 💗
Canadians shouldn’t have to explain why they need #HIV prevention medications in order to access them, according to the latest clinical guidelines.
Listen to the full @cbcradiocanada.bsky.social segment here: https://bit.ly/48DVTC4
Listen to the full @cbcradiocanada.bsky.social segment here: https://bit.ly/48DVTC4
December 9, 2025 at 8:30 PM
Canadians shouldn’t have to explain why they need #HIV prevention medications in order to access them, according to the latest clinical guidelines.
Listen to the full @cbcradiocanada.bsky.social segment here: https://bit.ly/48DVTC4
Listen to the full @cbcradiocanada.bsky.social segment here: https://bit.ly/48DVTC4
CTN+ National Director Dr. Marina Klein said, "These regionally led projects focus on implementing coordinated, national platforms that support training and mentorship, knowledge mobilization, and infrastructure for adaptive and community-informed research."
Learn more here: bit.ly/4onnOMq
Learn more here: bit.ly/4onnOMq
December 8, 2025 at 9:59 PM
CTN+ National Director Dr. Marina Klein said, "These regionally led projects focus on implementing coordinated, national platforms that support training and mentorship, knowledge mobilization, and infrastructure for adaptive and community-informed research."
Learn more here: bit.ly/4onnOMq
Learn more here: bit.ly/4onnOMq
We are excited to announce the successful funding of the CTN+ Phase 2 grants from the CIHR Institute of Infection & Immunity! 🎊
Phase 2 initiative aims to strengthen Canada’s capacity for inclusive, community-engaged clinical trials in #HIV and other STBBIs. (1/2)
Phase 2 initiative aims to strengthen Canada’s capacity for inclusive, community-engaged clinical trials in #HIV and other STBBIs. (1/2)
December 8, 2025 at 6:44 PM
We are excited to announce the successful funding of the CTN+ Phase 2 grants from the CIHR Institute of Infection & Immunity! 🎊
Phase 2 initiative aims to strengthen Canada’s capacity for inclusive, community-engaged clinical trials in #HIV and other STBBIs. (1/2)
Phase 2 initiative aims to strengthen Canada’s capacity for inclusive, community-engaged clinical trials in #HIV and other STBBIs. (1/2)
Are you a Canadian clinician?
Then make sure you don't miss the 2025 updates to the HIV PrEP and PEP guidelines.
“These options mean that clinicians have a lot of flexibility to offer their patients," said Dr. Darrell Tan, who led the initiative.
Check out our article: https://bit.ly/49i1q3c
Then make sure you don't miss the 2025 updates to the HIV PrEP and PEP guidelines.
“These options mean that clinicians have a lot of flexibility to offer their patients," said Dr. Darrell Tan, who led the initiative.
Check out our article: https://bit.ly/49i1q3c
December 3, 2025 at 8:01 PM
Are you a Canadian clinician?
Then make sure you don't miss the 2025 updates to the HIV PrEP and PEP guidelines.
“These options mean that clinicians have a lot of flexibility to offer their patients," said Dr. Darrell Tan, who led the initiative.
Check out our article: https://bit.ly/49i1q3c
Then make sure you don't miss the 2025 updates to the HIV PrEP and PEP guidelines.
“These options mean that clinicians have a lot of flexibility to offer their patients," said Dr. Darrell Tan, who led the initiative.
Check out our article: https://bit.ly/49i1q3c
Did you attend EACS 2025 this past October? 👀
No worries if you didn't get the chance. 🤠We've rounded up all of the new CTN+ research shared at the conference, along with summaries of some of the top headlines from international research teams.
Read the full report here: https://bit.ly/48tSGoD
No worries if you didn't get the chance. 🤠We've rounded up all of the new CTN+ research shared at the conference, along with summaries of some of the top headlines from international research teams.
Read the full report here: https://bit.ly/48tSGoD
December 2, 2025 at 8:02 PM
Did you attend EACS 2025 this past October? 👀
No worries if you didn't get the chance. 🤠We've rounded up all of the new CTN+ research shared at the conference, along with summaries of some of the top headlines from international research teams.
Read the full report here: https://bit.ly/48tSGoD
No worries if you didn't get the chance. 🤠We've rounded up all of the new CTN+ research shared at the conference, along with summaries of some of the top headlines from international research teams.
Read the full report here: https://bit.ly/48tSGoD
Supported by the CTN+ and led by Dr. Darrell Tan, this update presents 31 recommendations and 10 good practice statements to support clinical decision making for HIV #PrEP and #PEP.
Learn more about the changes to the guidelines and how they are set to empower patients: bit.ly/4pHnjxV
(2/2)
Learn more about the changes to the guidelines and how they are set to empower patients: bit.ly/4pHnjxV
(2/2)
December 2, 2025 at 5:18 PM
Supported by the CTN+ and led by Dr. Darrell Tan, this update presents 31 recommendations and 10 good practice statements to support clinical decision making for HIV #PrEP and #PEP.
Learn more about the changes to the guidelines and how they are set to empower patients: bit.ly/4pHnjxV
(2/2)
Learn more about the changes to the guidelines and how they are set to empower patients: bit.ly/4pHnjxV
(2/2)
"Overcoming disruption, transforming the AIDS response"
That's the theme of Worlds AIDS Day 2025, and it is light of that theme that we are so pleased to announce the updated Canadian PrEP and PeP Guidelines, published in @cmaj.ca! (1/2)
That's the theme of Worlds AIDS Day 2025, and it is light of that theme that we are so pleased to announce the updated Canadian PrEP and PeP Guidelines, published in @cmaj.ca! (1/2)
December 1, 2025 at 10:30 PM
"Overcoming disruption, transforming the AIDS response"
That's the theme of Worlds AIDS Day 2025, and it is light of that theme that we are so pleased to announce the updated Canadian PrEP and PeP Guidelines, published in @cmaj.ca! (1/2)
That's the theme of Worlds AIDS Day 2025, and it is light of that theme that we are so pleased to announce the updated Canadian PrEP and PeP Guidelines, published in @cmaj.ca! (1/2)
Congratulations, Darrel, for all the work you and the rest of the team poured into this important update to Canadian guidelines!
Proud to announce on World AIDS Day today that our 2025 update to Canadian guideline on HIV PrEP and PEP is now published in @cmaj.ca! The guideline include 31 recommendations and 10 good practice statements to support clinical decision making.
Learn more 👉 doi.org/10.1503/cmaj...
Learn more 👉 doi.org/10.1503/cmaj...
December 1, 2025 at 5:50 PM
Congratulations, Darrel, for all the work you and the rest of the team poured into this important update to Canadian guidelines!
Now published in @cmaj.ca: a 2025 update to Canadian guidelines on HIV PrEP and PEP.
Led by CTN+’s Dr. Darrell Tan, these guidelines include 31 recommendations and 10 good practice statements to support clinical decision making, developed by experts from across Canada.
👉 https://bit.ly/3MyNfNG
Led by CTN+’s Dr. Darrell Tan, these guidelines include 31 recommendations and 10 good practice statements to support clinical decision making, developed by experts from across Canada.
👉 https://bit.ly/3MyNfNG
December 1, 2025 at 5:20 PM
Now published in @cmaj.ca: a 2025 update to Canadian guidelines on HIV PrEP and PEP.
Led by CTN+’s Dr. Darrell Tan, these guidelines include 31 recommendations and 10 good practice statements to support clinical decision making, developed by experts from across Canada.
👉 https://bit.ly/3MyNfNG
Led by CTN+’s Dr. Darrell Tan, these guidelines include 31 recommendations and 10 good practice statements to support clinical decision making, developed by experts from across Canada.
👉 https://bit.ly/3MyNfNG
Abstract submissions are now being accepted for AIDS 2026, the 26th International AIDS Conference. It'll be taking place both virtually and in Rio de Janeiro, Brazil, July 26-31 2026.
Have an abstract to present? Be sure to submit by the January 26th deadline!
https://bit.ly/43QYhDX
Have an abstract to present? Be sure to submit by the January 26th deadline!
https://bit.ly/43QYhDX
November 29, 2025 at 6:02 PM
Abstract submissions are now being accepted for AIDS 2026, the 26th International AIDS Conference. It'll be taking place both virtually and in Rio de Janeiro, Brazil, July 26-31 2026.
Have an abstract to present? Be sure to submit by the January 26th deadline!
https://bit.ly/43QYhDX
Have an abstract to present? Be sure to submit by the January 26th deadline!
https://bit.ly/43QYhDX